Metal–organic frameworks for biological applications
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Metal–organic frameworks (MOFs) have emerged as exciting potential new candidates for application across nanomedicine, with the first example now in a phase II human clinical trial. MOFs have a range of desirable properties that make them suitable for various applications, including drug delivery, imaging and new treatment modalities, often in concert. In this Primer, we present an overview of the application of MOFs in biomedicine, focusing on drug delivery and imaging, but highlighting the chemical and structural versatility that is enabling their implementation in emerging treatment modalities and new biological applications. We discuss best practices in synthesis, characterization and application, including ongoing issues with reproducibility and limitations of applications, ending with an outlook of the field. Metal–organic frameworks have a range of desirable properties that make them suitable for application in drug delivery, imaging and new treatment modalities. In this Primer, Lázaro et al. discuss the best practices in synthesis and characterization of metal–organic frameworks for biomedicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pearson, R. G. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00905a001 · Cited by 10,475 · cited 1×
“NanoMOF stability can be predicted using Pearson’s hard and soft acids and bases principle 40 , in which more stable coordination bonds result from combining hard metals (Ti 4+ , Zr 4+ , Cr 3+ , Al 3+ and Fe 3+ ) with hard organic linkers (phosphonates and carboxylates) and soft metals (Cu 2+ and…”
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Normality Tests for Statistical Analysis: A Guide for Non-Statisticians
Ghasemi, A., & Zahediasl, S. (2012) · International Journal of Endocrinology and Metabolism · doi:10.5812/ijem.3505 · Cited by 4,368 · cited 1×
“Several statistical tests are available to compare the variance among groups 143 .”
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
Three-dimensional in vitro cell culture models in drug discovery and drug repositioning
Langhans, S. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00006 · Cited by 1,522
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
BioMOFs: Metal–Organic Frameworks for Biological and Medical Applications
McKinlay, A. C., Morris, R. E., Horcajada, P., Férey, G., Gref, R., Couvreur, P., & Serre, C. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000048 · Cited by 1,256 · cited 2×
“Fast and uncontrolled drug release is usually caused by weak host−guest interactions, inadequate pore size of the nanoMOFs, unfa-vourable hydrophobic/hydrophilic properties or rapid nanoMOF degradation 9,23,109,110 .”
Self-citationThe economics of reproducibility in preclinical research
Freedman, L. P., Cockburn, I. M., & Simcoe, T. S. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002165 · Cited by 1,055 · cited 1×
“Reproducibility has long been recognized as a major issue in preclinical research, impacting technological development and inducing significant economic cost 225 ; such concerns are particularly prevalent in drug delivery research 226,227 .”
He, C., Lu, K., Liu, D., & Lin, W. (2014) · Journal of the American Chemical Society · doi:10.1021/ja4098862 · Cited by 885 · cited 1×
“168), whereas other oligonucleotides have been covalently 64 and coordinatively 66 bonded to external surfaces of MOFs.”
Self-citationAlsaiari, S. K., Patil, S., Alyami, M., Alamoudi, K. O., Aleisa, F. A., Merzaban, J. S., Li, M., & Khashab, N. M. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b11754 · Cited by 517 · cited 1×
“More complex examples include the one-pot co-encapsulation of CRISPR–Cas9 by ZIF-8, with a loading efficiency of 17% for the protein/RNA gene editing platform, resulting in enhanced endosomal escape and gene knockdown in vitro 163 .”
The Costs of using Unauthenticated, Over-Passaged Cell Lines: How Much more Data do we Need?
Hughes, P., Marshall, D., Reid, Y., Parkes, H., & Gelber, C. (2007) · BioTechniques · doi:10.2144/000112598 · Cited by 434 · cited 1×
“Key experimental variables that can affect in vitro experiments, for example, the passage number of a Primer particular cell culture 229 or cell seeding density, are often missing from publications.”
The ghosts of HeLa: How cell line misidentification contaminates the scientific literature
Horbach, S. P. J. M., & Halffman, W. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186281 · Cited by 167 · cited 1×
“Coupled with the ongoing issue of cell-line contamination and misiden-tification 232 , it is advisable to thoroughly examine historical data when contextualizing new results.”
The rabbit as a model for reproductive and developmental toxicity studies
Foote, R. H., & Carney, E. W. (2000) · Reproductive Toxicology · doi:10.1016/s0890-6238(00)00101-5 · Cited by 164
Cited by
Nanoscale Mixed-Ligand Metal–Organic Framework for X-ray Stimulated Cancer Therapy
Zhen, W., Xu, Z., Mao, Y., McCleary, C., Jiang, X., Weichselbaum, R. R., & Lin, W. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c12140 · Cited by 37
Self-citation
Metadata
- Authors
- Abánades Lázaro, I., Chen, X., Ding, M., Eskandari, A., Fairen-Jimenez, D., Giménez-Marqués, M., Gref, R., Lin, W., Luo, T., & Forgan, R. S.
- Venue
- Nature Reviews Methods Primers
- Published
- 2024-06-27
- Volume
- 4
- Issue
- 1
- ISSN
- 2662-8449 (ISSN-L)
- OpenAlex
- W4400092487
- Cited by
- 252
- References
- 14
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.